Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Senti Biosciences Holdings Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NM
NEA Management Company, LLC
|
3.8M | 12.12% | Unchanged | 2022 | 0.3% | |
|
Shares held by quarter
Peak holding3.8M (Q1'25)
Change over 8 quarters+3.3M
Share of the company12.120%
|
||||||
|
NC
Nantahala Capital Management, LLC
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
Peak holding888.0K (Q1'25)
Change over 8 quarters0
|
||||||
20 more super investors behind a free account
See every manager holding Senti Biosciences Holdings Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$406K | 368.9K | 1.18% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$185K | 168.6K | 0.54% | 0.00% | June 30, 2026 |
7 more funds behind a free account
See every fund holding Senti Biosciences Holdings Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CP
Celadon Partners SPV 24
5%+ holder
13D · 54.6%
|
25.7M | 82.67% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
BH
Bayer HealthCare LLC
5%+ holder
13D · 17.8%
|
6.1M | 19.72% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Senti Biosciences Holdings Inc.
Sign up freeLoading...